Psoriatic arthritis and diabetes: A population-based cross-sectional study

Dermatology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Dreiher, Jacob ^a   Freud, Tamar ^a   Cohen, Arnon D ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSORIATIC ARTHRITIS; SEX DIFFERENCE;

EID: 84880144498     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2013/580404     Document Type: Article

References (43)

1. Christophers E., Psoriasis-epidemiology and clinical spectrum. Clinical and Experimental Dermatology 2001 26 4 314 320 2-s2.0-0035724176 10.1046/j.1365-2230.2001.00832.x
2. Wilson F. C., Icen M., Crowson C. S., McEvoy M. T., Gabriel S. E., Kremers H. M., Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. Journal of Rheumatology 2009 36 2 361 367 2-s2.0-64849114542 10.3899/jrheum.080691
3. Han C., Robinson D. W. Jr., Hackett M. V., Paramore L. C., Fraeman K. H., Bala M. V., Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Journal of Rheumatology 2006 33 11 2167 2172 2-s2.0-33751012122
4. Kimhi O., Caspi D., Bornstein N. M., Maharshak N., Gur A., Arbel Y., Comaneshter D., Paran D., Wigler I., Levartovsky D., Berliner S., Elkayam O., Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Seminars in Arthritis and Rheumatism 2007 36 4 203 209 2-s2.0-33846708186 10.1016/j.semarthrit.2006.09.001
5. Henseler T., Christophers E., Disease concomitance in psoriasis. Journal of the American Academy of Dermatology 1995 32 6 982 986 2-s2.0-0029053726 10.1016/0190-9622(95)91336-X
6. Shapiro J., Cohen A. D., David M., Hodak E., Chodik G., Viner A., Kremer E., Heymann A., The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A Case-Control Study. Journal of the American Academy of Dermatology 2007 56 4 629 634 2-s2.0-33947139769 10.1016/j.jaad.2006.09.017
7. Lindegard B., Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986 172 6 298 304 2-s2.0-0022461338
8. Neimann A. L., Shin D. B., Wang X., Margolis D. J., Troxel A. B., Gelfand J. M., Prevalence of cardiovascular risk factors in patients with psoriasis. Journal of the American Academy of Dermatology 2006 55 5 829 835 2-s2.0-33749662118 10.1016/j.jaad.2006.08.040
9. Pearce D. J., Morrison A. E., Higgins K. B., The comorbid state of psoriasis patients in a university dermatology practice. Journal of Dermatological Treatment 2005 16 5-6 319 323 2-s2.0-31644434594 10.1080/09546630500335977
10. Sommer D. M., Jenisch S., Suchan M., Christophers E., Weichenthal M., Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Archives of Dermatological Research 2006 298 7 321 328 2-s2.0-33751181855 10.1007/s00403-006-0703-z
11. Cohen A. D., Dreiher J., Shapiro Y., Vidavsky L., Vardy D. A., Davidovici B., Meyerovitch J., Psoriasis and diabetes: a population-based cross-sectional study. Journal of the European Academy of Dermatology and Venereology 2008 22 5 585 589 2-s2.0-42149124866 10.1111/j.1468-3083.2008.02636.x
12. Späh F., Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. British Journal of Dermatology 2008 159 supplement 2 10 17 2-s2.0-49249089910 10.1111/j.1365-2133.2008.08780.x
13. Kimball A. B., Robinson D. Jr., Wu Y., Guzzo C., Yeilding N., Paramore C., Fraeman K., Bala M., Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008 217 1 27 37 2-s2.0-46049086577 10.1159/000121333
14. Wu Y., Mills D., Bala M., Psoriasis: cardiovascular risk factors and other disease comorbidities. Journal of Drugs in Dermatology 2008 7 4 373 377 2-s2.0-46749152651
15. Mallbris L., Ritchlin C. T., Ståhle M., Metabolic disorders in patients with psoriasis and psoriatic arthritis. Current Rheumatology Reports 2006 8 5 355 363 2-s2.0-33750400902 10.1007/s11926-006-0065-8
16. Gottlieb A. B., Dann F., Menter A., Psoriasis and the metabolic syndrome. Journal of Drugs in Dermatology 2008 7 6 563 572 2-s2.0-47249124400
17. Qureshi A. A., Choi H. K., Setty A. R., Curhan G. C., Psoriasis and the risk of diabetes and hypertension: a prospective study of us female nurses. Archives of Dermatology 2009 145 4 379 382 2-s2.0-65349182400 10.1001/archdermatol.2009.48
18. Johnsson H., McInnes I. B., Sattar N., Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Annals of the Rheumatic Diseases 2012 71 4 480 483 2-s2.0-84857916300 10.1136/annrheumdis-2011-200567
19. Peters M. J., Van Der Horst-Bruinsma I. E., Dijkmans B. A., Nurmohamed M. T., Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Seminars in Arthritis and Rheumatism 2004 34 3 585 592 2-s2.0-10444270912 10.1016/j.semarthrit.2004.07.010
20. Farragher T. M., Bruce I. N., Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads. Journal of Rheumatology 2006 33 11 2105 2107 2-s2.0-33751009651
21. Armesto S., Santos-Juanes J., Galache-Osuna C., Martinez-Camblor P., Coto E., Coto-Segura P., Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population. Australasian Journal of Dermatology 2012 53 2 128 130 2-s2.0-80051796261 10.1111/j.1440-0960.2011.00802.x
22. Chung C. P., Avalos I., Oeser A., Gebretsadik T., Shintani A., Raggi P., Stein C. M., High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Annals of the Rheumatic Diseases 2007 66 2 208 214 2-s2.0-33846893474 10.1136/ard.2006.054973
23. Chung C. P., Oeser A., Solus J. F., Avalos I., Gebretsadik T., Shintani A., Raggi P., Sokka T., Pincus T., Stein C. M., Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008 196 2 756 763 2-s2.0-38649111368 10.1016/j.atherosclerosis.2007.01.004
24. Mok C. C., Ko G. T. C., Ho L. Y., Yu K. L., Chan P. T., To C. H., Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care and Research 2011 63 2 195 202 2-s2.0-79551512144 10.1002/acr.20363
25. Tam L. S., Tomlinson B., Chu T. T. W., Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology 2008 47 5 718 723 2-s2.0-42949130030 10.1093/rheumatology/ken090
26. Rennert G., Peterburg Y., Prevalence of selected chronic diseases in Israel. Israel Medical Association Journal 2001 3 6 404 408 2-s2.0-0035718667
27. Vinker S., Fogelman Y., Elhayany A., Nakar S., Kahan E., Usefulness of electronic databases for the detection of unrecognized diabetic patients. Cardiovascular Diabetology 2003 2, article 13 2-s2.0-2942573470 10.1186/1475-2840-2-13
28. Hahn B. H., Grossman J., Chen W., McMahon M., The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. Journal of Autoimmunity 2007 28 2-3 69 75 2-s2.0-34247624485 10.1016/j.jaut.2007.02.004
29. Solomon D. H., Love T. J., Canning C., Schneeweiss S., Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases 2010 69 12 2114 2117 2-s2.0-78649741346 10.1136/ard.2009.125476
30. Franconi F., Seghieri G., Canu S., Straface E., Campesi I., Malorni W., Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacological Research 2008 57 1 6 18 2-s2.0-39149104626 10.1016/j.phrs.2007.11.007
31. Saltevo J., Vanhala M., Kautiainen H., Kumpusalo E., Laakso M., Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: A Population-Based Study. Diabetic Medicine 2008 25 6 747 750 2-s2.0-44649193809 10.1111/j.1464-5491.2008.02440.x
32. Gulliver W., Long-term prognosis in patients with psoriasis. British Journal of Dermatology 2008 159 supplement 2 2 9 2-s2.0-49249102223 10.1111/j.1365-2133.2008.08779.x
33. Boehncke W. H., Boehncke S., Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences. Giornale Italiano di Dermatologia e Venereologia 2008 143 5 307 313 2-s2.0-55949117915
34. Liu Y., Helms C., Liao W., Zaba L. C., Duan S., Gardner J., Wise C., Miner A., Malloy M. J., Pullinger C. R., Kane J. P., Saccone S., Worthington J., Bruce I., Kwok P., Menter A., Krueger J., Barton A., Saccone N. L., Bowcock A. M., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genetics 2008 4 4 2-s2.0-43249083380 10.1371/journal.pgen.1000041 e1000041
35. Yudkin J. S., Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology. Diabetologia 2007 50 8 1576 1586 2-s2.0-34447124617 10.1007/s00125-007-0711-3
36. Sonnenberg G. E., Krakower G. R., Kissebah A. H., A novel pathway to the manifestations of metabolic syndrome. Obesity Research 2004 12 2 180 186 2-s2.0-2942698938
37. Channual J., Wu J. J., Dann F. J., Effects of tumor necrosis factor- α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatologic Therapy 2009 22 1 61 73 2-s2.0-60649121623 10.1111/j.1529-8019.2008.01217.x
38. Yoo H., Kim S., Kim Y., Lee H., Kim T., Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. International Journal of Biochemistry and Cell Biology 2007 39 6 1248 1259 2-s2.0-34249303782 10.1016/j.biocel.2007. 04.009
39. Das S. K., Elbein S. C., The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Current Diabetes Reports 2007 7 2 154 164 2-s2.0-34248398040 10.1007/s11892-007-0025-3
40. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G. B., Styrkarsdottir U., Gretarsdottir S., Emilsson V., Ghosh S., Baker A., Snorradottir S., Bjarnason H., Ng M. C. Y., Hansen T., Bagger Y., Wilensky R. L., Reilly M. P., Adeyemo A., Chen Y., Zhou J., Gudnason V., Chen G., Huang H., Lashley K., Doumatey A., So W., Ma R. C. Y., Andersen G., Borch-Johnsen K., Jorgensen T., Van Vliet-Ostaptchouk J. V., Hofker M. H., Wijmenga C., Christiansen C., Rader D. J., Rotimi C., Gurney M., Chan J. C. N., Pedersen O., Sigurdsson G., Gulcher J. R., Thorsteinsdottir U., Kong A., Stefansson K., A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genetics 2007 39 6 770 775 2-s2.0-34249828965 10.1038/ng2043
41. Wolf N., Quaranta M., Prescott N. J., Allen M., Smith R., Burden A. D., Worthington J., Griffiths C. E. M., Mathew C. G., Barker J. N., Capon F., Trembath R. C., Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. Journal of Medical Genetics 2008 45 2 114 116 2-s2.0-39149111552 10.1136/jmg.2007.053595
42. Boehncke W. H., Sterry W., Psoriasis-a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives. Journal der Deutschen Dermatologischen Gesellschaft 2009 7 11 946 952 10. 1111/j. 1610-0387. 2009. 07083.x
43. Bongartz T., Coras B., Vogt T., Schölmerich J., Müller-Ladner U., Treatment of active psoriatic arthritis with the PPAR γ ligand pioglitazone: an open-label pilot study. Rheumatology 2005 44 1 126 129 2-s2.0-12344282955 10.1093/rheumatology/keh423